INC.

AMYRIS COMPLETES LICENSE FOR SUPPLY OF SUSTAINABLE SQUALENE

by

EMERYVILLE, Calif., May 19, 2023 Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world’s transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it has signed an exclusive license agreement with British specialty chemicals company Croda International Plc, (“Croda”) for the supply of sustainable squalene. … Read more

DocuSign Announces Timing of First Quarter Fiscal 2024 Earnings Conference Call

by

SAN FRANCISCO, May 18, 2023 /PRNewswire/ — DocuSign (Nasdaq: DOCU) today announced that its first quarter fiscal 2024 results will be released on Thursday, June 8, 2023, after the close of the market. The company will host a conference call at 1:30 p.m. Pacific Standard Time (4:30 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will … Read more

Perimeter Medical Imaging AI Announces Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Corporate Update

by

Hosting Call on Thursday, May 25th at 5 pm ET TORONTO and DALLAS, May 18, 2023 /PRNewswire/ – Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) – a commercial-stage medical technology company – announced it will report its first quarter 2023 financial and operating results after the close … Read more

Women’s Health Market to Reach $63.02 Billion by 2030: Grand View Research, Inc.

by

SAN FRANCISCO, May 18, 2023 /PRNewswire/ — The global women’s health market size is expected to reach USD 63.02 billion by 2030, registering a CAGR of 5.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction of innovative novel products and the presence of a strong pipeline of women’s … Read more

ImaginAb Advances Two Solid Tumor Radiopharmaceutical Therapy (RPT) Candidates Towards Clinical Development

by

IAB56 RPT agent is designed to target integrin αvβ6, a receptor over-expressed in a broad range of solid cancers underserved by current cancer therapies. IAB57 RPT agent is designed to target DLL3, a target over-expressed in cancer tissues and relevant in several cancers, most notably Small-Cell Lung Cancer (SCLC) LOS ANGELES, May 18, 2023 /PRNewswire/ … Read more

ImaginAb Advances Two Solid Tumor Radiopharmaceutical Therapy (RPT) Candidates Towards Clinical Development

by

IAB56 RPT agent is designed to target integrin αvβ6, a receptor over-expressed in a broad range of solid cancers underserved by current cancer therapies. IAB57 RPT agent is designed to target DLL3, a target over-expressed in cancer tissues and relevant in several cancers, most notably Small-Cell Lung Cancer (SCLC) LOS ANGELES, May 18, 2023 /PRNewswire/ … Read more

FzioMed Announces Addition of Industry Veteran to its Board of Directors

by

Company sets refreshed global strategy and new US initiatives for Oxiplex® portfolio of adhesion barrier products in women’s health, spine, orthopedics and general surgery. SAN LUIS OBISPO, Calif., May 17, 2023 /PRNewswire/ — FzioMed, Inc. (“FzioMed” or the “Company”), a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, today announced … Read more

UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES DIVIDEND

by

KING OF PRUSSIA, Pa., May 17, 2023 /PRNewswire/ — Universal Health Services, Inc. (NYSE: UHS) announced today that its Board of Directors voted to pay a cash dividend of $0.20 per share on June 15, 2023 to shareholders of record as of June 1, 2023. Universal Health Services, Inc. (“UHS”) is one of the nation’s … Read more

Curaleaf Reports First Quarter 2023 Results

by

First quarter 2023 revenue of $336.5 million, representing an increase of 14% year-over-year, and adjusted EBITDA(1) of $73.2 million Operating cash flow from continuing operations of $30.6 million and cash on balance sheet of $115.8 million NEW YORK, May 17, 2023 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer … Read more

Community Healthcare Trust Incorporated Announces Appointment of Bill Monroe as Chief Financial Officer

by

FRANKLIN, Tenn., May 17, 2023 /PRNewswire/ — Community Healthcare Trust Incorporated (NYSE: CHCT) (the “Company”) today announced that its Board of Directors appointed William G. Monroe IV to be the Company’s Chief Financial Officer, effective as of June 1, 2023.  David H. Dupuy, the Company’s Chief Executive Officer, said, “On behalf of the Company, we are … Read more